TABLE 1.

Details of SIV_mac251-infected pig-tailed macaques used in this study^a

Study	No. of macaques	Vaccine	ART	Challengeb	Outcome of vaccine	Reference
1	11	Kunjin SIV	No	SIVmac251, intravenously	No effect	29
2	31	Peptide immunotherapy (n = 21) or control (n = 10)	Yesc	SIVmac251, intravenously	Immunotherapy effective	31
3	2	Influenza virus-SIV	No	SIVmac251, intrarectally	No effect	30

^aA total of 44 macaques were studied.

^bThe same stock of SIV_mac251, supplied by R. Pal and N. Miller, was used for all infections.

^cThe animals received ART from weeks 3 to 10 after infection.